Michael Auerbach
General Partner & Founder @ Subversive Capital
New York, United States
Michael Auerbach is a seed investor at Subversive Capital in New York focused on Cannabis and Marketplace. Michael Auerbach is the Chairman at The Parent Company.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 22%
Last updated:
For AI agents: llms.txt
Industries Michael Auerbach invests in
Stages Michael Auerbach invests in
Countries Michael Auerbach invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $1.7M–$2.5M
- Series A
- $5M–$7M
- Series B
- $40M–$43M
Investment Focus
Industry
- Cannabis 3 (33%)
- Marketplace 2 (22%)
- B2B 1 (11%)
- SaaS 1 (11%)
- Sales 1 (11%)
Stage
- Seed 2 (22%)
- Series A 2 (22%)
- Series B 2 (22%)
- Convertible Note 2 (22%)
- Series D 1 (11%)
Country
- United States 6 (67%)
- Canada 1 (11%)
- Germany 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Pure Beauty is an e-commerce platform that offers products in different categories. | $5M / Convertible Note / Jul 15, 2021 | ||
| Pure Beauty is a cannabis brand located in Los Angeles. | $5M / Convertible Note / Jul 15, 2021 | ||
| Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic. | $40M / Series B / Jun 03, 2021 | ||
| ATAI is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering from mental health disorders. The company is committed to acquiring and efficiently developing innovative treatments that address significant unmet medical needs and lead to paradigm shifts in themental health space.ATAI Life Sciences was founded in 2018 and is based in Munich, Bayern, Germany. | $157M / Series D / Mar 03, 2021 | ||
| Sweet Reason is a hemp and cannabis beverage company that launched with three naturally flavored, CBD-infused sparkling waters (Grapefruit, Cucumber Mint, and Strawberry Lavender) made in the USA. Each 12 oz bottle CO2-extracted CBD from Colorado organic hemp and contains no sugar, sweeteners, sodium, carbohydrates or artificial ingredients and isjust five calories. | $2.5M / Seed / Jul 02, 2019 | ||
| Duco is an online marketplace that features direct messaging, single point of billing, and project management dashboard. The company focuses on policy, global affairs, international affairs, consulting, SaaS, global, and international. The company was founded in 2016 and headquartered in California, United States. | $1M / Seed / May 03, 2019 | ||
| ATAI is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering from mental health disorders. The company is committed to acquiring and efficiently developing innovative treatments that address significant unmet medical needs and lead to paradigm shifts in themental health space.ATAI Life Sciences was founded in 2018 and is based in Munich, Bayern, Germany. | $43M / Series B / Mar 01, 2019 | ||
| With Roomer Flex cancellation protection, customers can cancel their vacation for any reason – with no questions asked. Roomer has already protected hundreds of thousands of travelers, with tens of millions of dollars’ worth of travel reservations. In a very different way from existing insurance companies - When the vacation is cancelled by thecustomer, Roomer distributes the cancelled reservation in its travel marketplace and distribution network, including Trivago (Expedia), Kayak (Priceline), Skyscanner (Ctrip) and more – and efficiently reduces the costs for travelers. | $5M / Series A / Nov 25, 2014 | ||
| Privateer is a private equity firm shaping the future of legal cannabis. Privateer Holdings represents a group of investors from around the world seeking to end cannabis prohibition and the social harms it causes.Through a combination of acquisitions, investments and incubation, Privateer is focused on building a portfolio of global brands thatwill lead, legitimize and define the future of cannabis.The current portfolio includes: Leafly, the world's cannabis information resource; Tilray, a leading global producer of medical cannabis; and Marley Natural, the official cannabis and lifestyle brand of Bob Marley. | $7M / Series A / Jul 16, 2013 |
Co-Investors
About Subversive Capital
Subversive Capital is dedicated to investing in radical companies whose core missions subvert the status quo and require sophisticated government and regulatory strategies for success.
Subversive Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Adam Rothstein
General Partner
|
|||
|
Michael Auerbach
General Partner & Founder
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Michael Auerbach invest in?
Michael Auerbach invests primarily in Cannabis, Marketplace and B2B startups, most often at Seed and Series A stage. Most of the 9 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Michael Auerbach's check size?
Michael Auerbach typically joins rounds of $1.7M–$2.5M at Seed, $5M–$7M at Series A and $40M–$43M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Michael Auerbach participates in.
How do I contact Michael Auerbach?
Public channels for Michael Auerbach include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Michael Auerbach last invest?
The most recent investment recorded for Michael Auerbach closed in Jul 2021. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
